首页> 外文期刊>Endocrine. >Reply to “Predictors of surgical outcome and early criteria of remission in acromegaly—some controversial issues”
【24h】

Reply to “Predictors of surgical outcome and early criteria of remission in acromegaly—some controversial issues”

机译:回复“在仇集争夺性问题中的外科结果和早期缓解的预测性 - 一些有争议的问题”

获取原文
获取原文并翻译 | 示例
           

摘要

First, the authors questioned that we defined surgical remission with the GH and IGF-I levels 3 months after surgery. They cited their own unpublished data to question this time period of evaluation and also the last Endocrine Society guideline [3]. We agree that in some cases, normalization of IGF-I can take more than 12 weeks, but in these cases there is generally a great decrease of IGF-I levels after 12 weeks and, also, GH levels are below 1.0?μg/L. From the 38 patients not cured by surgery, only three patients presented GH levels below 1.0?μg/L 3 months after surgery. In these three patients, medical therapy with octreotide was started and despite 1 year of treatment with the maximum dose, they still presented elevated IGF-I levels, therefore, we can assure that they were not cured by surgery
机译:首先,作者质疑我们在手术后3个月与GH和IGF-I水平定义了手术缓解。 他们引用了自己未发表的数据来质疑这一时间的评估期,也是最后一个内分泌社会指南[3]。 我们同意在某些情况下,IGF-I的正常化可以花费超过12周,但在这些情况下,12周后,IGF-I水平通常会有很大的降低,并且,此外,GH水平低于1.0?μg/ L. 。 从38名没有通过手术治愈的患者,只有三名患者在手术后3个月内呈现低1.0℃以下的GH水平。 在这三名患者中,使用奥曲霉苷的医疗治疗开始,尽管含有最大剂量的1年治疗,但它们仍然呈现升高的IGF-I水平,因此,我们可以确保他们没有通过手术治愈

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号